The three major insulin manufacturers are lowering prices for Medicare patients, but cost is still a huge barrier to the effective treatment of type 2 diabetes which accounts for 90% of diabetes cases. This article reviews these changes in insulin pricing in detail. People who struggle with type 2 diabetes don’t just have the cost of insulin to consider. They usually have several other problems and they see multiple specialists. They may have diabetic eye disease, diabetic kidney disease, high blood pressure, high cholesterol, and artery disease. They may already be on multiple expensive medications and treatments. The eyeball injections for diabetic eye disease can cost $2000 a month. These price decreases for insulin only apply to certain categories of patients. The poor and disadvantaged are the people who most often need insulin and many of them have no insurance.
Hyperinsulinemia is the cause of severe complications of both Type I, II, and III Diabetes. Ketogenic diet is the way for the long haul. Too much insulin cause kidney failure, cardiovascular disease, hypertension, stroke, amputation, and poorly maintained wounds. It is the evil of the diabetic industry.
Hyperinsulinemia is the cause of severe complications of both Type I, II, and III Diabetes. Ketogenic diet is the way for the long haul. Too much insulin cause kidney failure, cardiovascular disease, hypertension, stroke, amputation, and poorly maintained wounds. It is the evil of the diabetic industry.